Stockscreener 앱 받기
37.00
2.50%
-0.95
시간 외 거래:
36.98
-0.02
-0.05%
전일 마감가:
$37.95
열려 있는:
$37.65
하루 거래량:
647.57K
Relative Volume:
0.64
시가총액:
$4.17B
수익:
$14.09M
순이익/손실:
$-176.94M
주가수익비율:
-17.21
EPS:
-2.15
순현금흐름:
$-141.24M
1주 성능:
+2.66%
1개월 성능:
+20.64%
6개월 성능:
+84.72%
1년 성능:
+107.63%
1일 변동 폭
$36.30
$37.99
1주일 범위
$35.50
$39.03
52주 변동 폭
$14.06
$41.47
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
명칭
Newamsterdam Pharma Company Nv
전화
35 206 2971
주소
GOOIMEER 2-35, NARRDEN
NAMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
37.00 | 4.27B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 재개 | H.C. Wainwright | Buy |
| 2025-08-25 | 개시 | Wells Fargo | Overweight |
| 2025-07-17 | 개시 | Goldman | Neutral |
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2025-06-10 | 개시 | Stifel | Buy |
| 2025-06-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-05-15 | 개시 | TD Cowen | Buy |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-18 | 개시 | Guggenheim | Buy |
| 2024-01-16 | 개시 | Piper Sandler | Overweight |
| 2023-10-30 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Newamsterdam Pharma Company Nv 주식(NAMS)의 최신 뉴스
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investors2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
Why NewAmsterdam Pharma Company N.V. stock is seen as undervaluedRate Cut & Weekly High Potential Stock Alerts - newser.com
Can NewAmsterdam Pharma Company N.V. Equity Warrant stock withstand economic slowdownInflation Watch & Real-Time Chart Pattern Alerts - newser.com
Assessing NewAmsterdam Pharma (NasdaqGM:NAMS) Valuation Ahead of Major Phase 3 Data Presentations - simplywall.st
How to escape a deep drawdown in NewAmsterdam Pharma Company N.V.Weekly Risk Report & Community Consensus Trade Signals - newser.com
Is NewAmsterdam Pharma Company N.V. stock poised for growthEarnings Summary Report & Growth Oriented Trade Recommendations - newser.com
NewAmsterdam Pharma Company N.V. recovery potential after sell offJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Why retail investors pile into NewAmsterdam Pharma Company N.V. Equity Warrant stockWeekly Stock Summary & Free Expert Verified Stock Movement Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock attractive post correctionMarket Risk Analysis & Pattern Based Trade Signal System - newser.com
Can NewAmsterdam Pharma Company N.V. (KH6) stock surprise markets with earningsWall Street Watch & Low Drawdown Trading Strategies - newser.com
Using economic indicators to assess NewAmsterdam Pharma Company N.V. Equity Warrant potentialJuly 2025 Movers & Daily Risk Controlled Trade Plans - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings seasonJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs in stagflation2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversalWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock reacts to oil pricesJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from upcoming earnings reports2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
How hedge fund analytics apply to NewAmsterdam Pharma Company N.V. stock2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com
Pattern recognition hints at NewAmsterdam Pharma Company N.V. upsideMarket Activity Recap & Daily Technical Forecast Reports - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock maintain momentum in 2025Share Buyback & Technical Entry and Exit Tips - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock trading at a premium valuationJuly 2025 Final Week & Reliable Momentum Entry Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock prepared for digital transitionMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock compares to market leadersEarnings Recap Summary & Risk Managed Investment Entry Signals - newser.com
Can volume confirm reversal in NewAmsterdam Pharma Company N.V. Equity WarrantMarket Rally & Community Verified Watchlist Alerts - newser.com
Visual analytics tools that track NewAmsterdam Pharma Company N.V. Equity Warrant performanceJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockWeekly Market Report & Community Consensus Picks - newser.com
Risk adjusted return profile for NewAmsterdam Pharma Company N.V. Equity Warrant analyzed2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Key resistance and support levels for NewAmsterdam Pharma Company N.V.July 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Using data models to predict NewAmsterdam Pharma Company N.V. Equity Warrant stock movement2025 Top Decliners & AI Driven Stock Reports - newser.com
NewAmsterdam Pharma Hits Day High with 8.05% Surge, Strong Intraday Performance - Markets Mojo
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock bottoming outBuy Signal & Fast Moving Stock Watchlists - newser.com
What does recent volatility data suggest for NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Published on: 2025-11-02 01:19:15 - newser.com
How to build a custom watchlist for NewAmsterdam Pharma Company N.V.Earnings Miss & Daily Entry Point Alerts - newser.com
NewAmsterdam Pharma (NAMS) Is Up 6.2% After Announcing Key Phase 3 Data Reveal at AHA 2025—Has The Bull Case Changed? - simplywall.st
Will NewAmsterdam Pharma Company N.V. stock maintain dividend yieldPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
Newamsterdam Pharma Company Nv (NAMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):